EOLS Competitors & Alternatives

Compare Evolus Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

EOLS

Main Stock
$6.90
Tradestie Score
58
Market Cap
$397.82M
Revenue Growth
0.1%
Analyst Upside
+112.6%

Top Competitors

48 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
CRON Cronos Group Inc. Common Share
$2.86
$1.02B - 62 Compare
ANAB AnaptysBio, Inc. Common Stock
$63.42
$894.30M - 57 Compare
EYPT EyePoint Pharmaceuticals, Inc. Common Stock
$13.98
$890.20M - 56 Compare
AQST Aquestive Therapeutics, Inc. Common Stock
$4.18
$711.32M - 54 Compare
ESPR Esperion Therapeutics, Inc.
$3.16
$584.71M - 59 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$37.50
$543.32M - 57 Compare
SLDB Solid Biosciences Inc. Common Stock
$10.84
$457.09M - 54 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.33
$237.15M 6.6 60 Compare
BIOA BioAge Labs, Inc. Common Stock
$25.10
$212.23M - 55 Compare
MGNX MacroGenics, Inc.
$4.71
$107.45M - 62 Compare

Data updated: Jul 04, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

48 stocks in this industry